Alzheimer's Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT07420075
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The design is an open-ended, prospective, observational, (non-interventional) registry for subjects with mild cognitive impairment (MCI), early symptomatic Alzheimer's disease, Alzheimer's disease, or dementia with clinical suspicion of Alzheimer's disease under the care of a neurologist, psychiatrist, geriatrician or other qualified provider. Longitudinal data are collected from subjects, their care partner(s), and their treating healthcare provider during routine clinical encounters using a structured and standardized data collection method. Approximately 2,000 subjects, with no defined upper limit, across around 75 clinical sites worldwide will be recruited.

Key Dates

Start date
Nov 24, 2025
Status verified
Dec 2025
Primary completion
Dec 31, 2099
Completion
Dec 31, 2099

Study Design

Enrollment
2,000 participants (estimated)

Primary Outcome Measure

Alzheimer Disease Epidemiology and presentation [ Time Frame: Every 6 months for 10 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451-

Find similar trials in Waltham, MA

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
CorEvitas, LLC· Waltham, MA

Related Studies